# Black Seed Oil Sleep Onset Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/black-seed-oil-sleep-onset-randomized-trial-evidence-review
Category: evidence-review
Summary: Black Seed Oil Sleep Onset Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-08-20
Reviewed by: Migaku Evidence Review
# Black Seed Oil Sleep Onset Randomized Trial: What the Evidence Says

## Quick Answer

Black Seed Oil Sleep Onset Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Randomised feasibility trial of a remotely delivered holistic UK employee programme combining tailored sleep hygiene, diet, and physical activity counselling for weight management: a mixed-methods evaluation | randomized trial | 2 | 2026-01-01 | 10.1017/jns.2026.10104 |
| The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs | narrative review | 3 | 2025-09-19 | 10.3390/molecules30183814 |

## What The Sources Report

- Emerging evidence highlights the need to address sleep, diet, and PA together, given their complex interactions affecting energy balance and health.However, few interventions take this integrated approach, with most excluding sleep, emphasising the need for comprehensive strategies targetingbehaviours simultaneously. [Du Preez Andrea (2026); evidence level 2]
- Developed by a multidisciplinary team, the King's Workplace Holistic Optimisation of Lifestyle and Energy (King's-WHOLE) Study sought to enhance sleep quality and duration, increase PA, and improve dietary practices among employees reporting inadequate sleep (<7 h) and a BMI indicative of increased cardiometabolic risk. [Du Preez Andrea (2026); evidence level 2]
- These disturbances occur despite adequate opportunity and conditions for sleep, and they result in general dissatisfaction with sleep quality and various daytime impairments. [&#379;e&#322;abowski Kacper (2025); evidence level 3]
- Individuals reporting nighttime symptoms without associated daytime dysfunction are not classified as having clinical insomnia. [&#379;e&#322;abowski Kacper (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For black seed oil sleep onset randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Du Preez Andrea (2026). Randomised feasibility trial of a remotely delivered holistic UK employee programme combining tailored sleep hygiene, diet, and physical activity counselling for weight management: a mixed-methods evaluation. DOI: 10.1017/jns.2026.10104. PMCID: PMC13279985. PMID: 42325726. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13279985/
- &#379;e&#322;abowski Kacper (2025). The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs. DOI: 10.3390/molecules30183814. PMCID: PMC12472680. PMID: 41011705. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12472680/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.